424 related articles for article (PubMed ID: 33031755)
21. Analysis of p53, BCL-2 and epidermal growth factor receptor protein expression in the partial and complete hydatidiform moles.
Hussein MR
Exp Mol Pathol; 2009 Aug; 87(1):63-9. PubMed ID: 19348791
[TBL] [Abstract][Full Text] [Related]
22. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
Persaud V; Ganjei P; Nadji M
West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
[TBL] [Abstract][Full Text] [Related]
23. Expression of HOX gene products in normal and abnormal trophoblastic tissue.
Amesse LS; Moulton R; Zhang YM; Pfaff-Amesse T
Gynecol Oncol; 2003 Sep; 90(3):512-8. PubMed ID: 13678718
[TBL] [Abstract][Full Text] [Related]
24. Telomerase activity in complete hydatidiform mole.
Bae SN; Kim SJ
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):328-33. PubMed ID: 9988795
[TBL] [Abstract][Full Text] [Related]
25. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
[TBL] [Abstract][Full Text] [Related]
26. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms.
Lei ZM; Rao CV; Ackerman DM; Day TG
J Clin Endocrinol Metab; 1992 Jun; 74(6):1236-41. PubMed ID: 1592864
[TBL] [Abstract][Full Text] [Related]
27. Practical guidelines of the EOTTD for pathological and genetic diagnosis of hydatidiform moles.
Bartosch C; Nadal A; Braga AC; Salerno A; Rougemont AL; Van Rompuy AS; Fitzgerald B; Joyce C; Allias F; Maher GJ; Turowski G; Tille JC; Alsibai KD; Van de Vijver K; McMahon L; Sunde L; Pyzlak M; Downey P; Wessman S; Patrier S; Kaur B; Fisher R
Virchows Arch; 2024 Mar; 484(3):401-422. PubMed ID: 37857997
[TBL] [Abstract][Full Text] [Related]
28. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles.
Sato A; Usui H; Shozu M
Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360
[TBL] [Abstract][Full Text] [Related]
29. Methylation status and expression of E-cadherin and cadherin-11 in gestational trophoblastic diseases.
Xue WC; Feng HC; Tsao SW; Chan KY; Ngan HY; Chiu PM; Maccalman CD; Cheung AN
Int J Gynecol Cancer; 2003; 13(6):879-88. PubMed ID: 14675328
[TBL] [Abstract][Full Text] [Related]
30. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
Asmar FTC; Braga-Neto AR; de Rezende-Filho J; Villas-Boas JMS; Charry RC; Maesta I
Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
[TBL] [Abstract][Full Text] [Related]
31. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of the Parkinson disease protein DJ-1 and its regulator PTEN in gestational trophoblastic disease.
Zhang HJ; Siu MK; Jiang LL; Mak VC; Ngan HY; Cheung AN
Int J Gynecol Pathol; 2010 Sep; 29(5):468-75. PubMed ID: 20736773
[TBL] [Abstract][Full Text] [Related]
33. Down-regulation of poly(rC)-binding protein 1 correlates with the malignant transformation of hydatidiform moles.
Shi Z; Zhang T; Long W; Wang X; Zhang X; Ling X; Ding H
Int J Gynecol Cancer; 2012 Sep; 22(7):1125-9. PubMed ID: 22801034
[TBL] [Abstract][Full Text] [Related]
34. Decidual infiltration of FoxP3⁺ regulatory T cells, CD3⁺ T cells, CD56⁺ decidual natural killer cells and Ki-67 trophoblast cells in hydatidiform mole compared to normal and ectopic pregnancies.
Sundara YT; Jordanova ES; Hernowo BS; Gandamihardja S; Fleuren GJ
Mol Med Rep; 2012 Jan; 5(1):275-81. PubMed ID: 22002546
[TBL] [Abstract][Full Text] [Related]
35. Indoleamine 2,3-dioxygenase expression in gestational trophoblastic disease: implications for development of immunotherapeutic approaches.
Sebire NJ; Fisher RA; Williams S; Prendergast G; Savage P; Seckl M
J Reprod Med; 2008 Oct; 53(10):789-92. PubMed ID: 19004406
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of PDCD4 by deSUMOylation associates with the progression of gestational trophoblastic disease.
Wang YX; Cui L; Wu WB; Quinn MJ; Menon R; Zhao JR; Zhang HJ
Placenta; 2022 Dec; 130():17-24. PubMed ID: 36370491
[TBL] [Abstract][Full Text] [Related]
37. Centralized surveillance of hydatidiform mole: 7-year experience from a regional hospital in China.
Jiao L; Wang Y; Jiang J; Wang X; Zhang W; Zhu C; Xiang Y
Int J Gynecol Cancer; 2022 Feb; 32(2):147-152. PubMed ID: 34799419
[TBL] [Abstract][Full Text] [Related]
38. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles.
Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R
Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356
[TBL] [Abstract][Full Text] [Related]
39. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts.
Kim YT; Cho NH; Ko JH; Yang WI; Kim JW; Choi EK; Lee SH
Cancer; 2000 Aug; 89(3):673-9. PubMed ID: 10931468
[TBL] [Abstract][Full Text] [Related]
40. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
Stone M; Bagshawe KD
Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
